Upcoming Webinars

Excellence in Research Webinar Series

Your trusted resource for cell lines, microbial strains, biological reagents, and innovative solutions announces the 2014 Excellence in Research webinar series. Each webinar will demonstrate how to utilize ATCC products and services to advance your research. The webinars will be broadcasted live at 10:00 AM and 3:00 PM ET, and will be followed by a question and answer period.


Shamaila Ashraf ATCC® Influenza Research Materials
Shamaila Ashraf, M.Sc, M.Phil, Ph.D., Senior Scientist, ATCC
September 11, 2014 10:00 AM ET or 3:00 PM ET

Influenza remains one of the most significant infectious diseases worldwide, causing acute respiratory tract illnesses and accounting for 25% of infections that exacerbate chronic lung infections. To date, several epidemics and four major influenza pandemics have been recorded. Influenza viruses have caused an estimated 3 million cases of serious illness and around 500,000 deaths annually worldwide. Influenza infections are primarily and effectively controlled by vaccines that elicit protective immunity. Influenza viruses undergo rapid antigenic shift and drift that results in the emergence of new strains each year. Therefore, influenza vaccines need to be reformulated every year to match the circulating strains. In this webinar, we will provide an overview of the influenza virus and will explore the current treatment strategies for influenza infections. We will also highlight viral strains and associated materials offered by ATCC that can be used in influenza research or in the development and validation of novel preventative and therapeutic techniques.
Register for a session - 10:00 AM ET or 3:00 PM ET.


Fang TianDavid H. RandleATCC® Genetic Alteration Cell Panels: Effective Tools for High Throughput Screening Using Corning® Epic® Technology

Fang Tian, Ph.D., Lead Scientist, ATCC
David H. Randle, Ph.D., Manager, Applications Development, Corning Life Sciences
September 18, 2014 10:00 AM ET or 3:00 PM ET

Extensive genomic™ sequencing efforts in recent years have provided detailed profiles of the somatic gene mutations that occur in a wide range of human cancers. In order to facilitate basic and translational cancer research, ATCC has designed and validated a number of Genetic Alteration Cell Panels targeting the key molecular pathways identified in these studies. To demonstrate suitability of the panels for high throughput screening, the EGFR panel was selected for evaluation using Corning Epic Technology, a label-free platform that uses optical biosensors for high sensitivity biochemical and cell-based assays. In this webinar, we will discuss how the combination of Epic Technology and the EGFR Genetic Alteration Panel offers convenient tools to screen for ligands or biologics that directly target or affect EGFR receptor biology.
Register for a session - 10:00 AM ET or 3:00 PM ET.


Tigwa DavisUsing LUHMES Cells as a Model System to Study Dopaminergic Neuron Cell Biology
Tigwa H. Davis, Ph.D., Senior Scientist, Neurobiology, ATCC
October 16, 2014 10:00 AM ET or 3:00 PM ET

Dopaminergic neurons play significant roles in motor, reward, and motivational behavior related circuits throughout the brain. To date, there are few continuous in vitro models available to laboratories in research, industry, and academia for studies related to basic dopaminergic cell biology or high throughput screening. Here, we propose the use of a human model system, LUHMES cells, to study dopaminergic neuron cell biology. During this webinar, we will highlight some of the advantages of using LUHMES cells, as well as examples of how they have been used in drug screening and to study the molecular mechanisms related to Parkinson’s Disease.
Register for a session - 10:00 AM ET or 3:00 PM ET.


Tigwa DavisPrecise Counting of Targeted Nucleic Acids has Never Been Easier
Francisco Bizouarn, Global Digital Applications Specialist, Digital Biology Center, Bio-Rad Laboratories
October 30, 2014 10:00 AM ET or 3:00 PM ET

Droplet Digital PCR (ddPCR) is an elegant technology that permits accurate and absolute quantification of target nucleic acid molecules. By subpartitioning a PCR reaction into thousands of nanoliter sized droplets, amplifying, and subsequently individually interrogating them, ddPCR allows for increased quantitative resolution, enhanced detection of difficult to amplify targets, better reproducibility, and simplified data analysis. This webinar will provide a technical overview of ddPCR from technical and workflow related perspectives as well as review key applications such as copy number variation (CNV) analysis, rare mutation detection (RMD) analysis, and standard free (stand-alone) absolute quantification of nucleic acids.
Register for a session - 10:00 AM ET or 3:00 PM ET.


John Pulliam3D Tissue Modeling
John Pulliam, Ph.D., Field Application Scientist, ATCC
November 13, 2014 10:00 AM ET or 3:00 PM ET

The emergence of 3D tissue modeling raises new possibilities for the study of complex physiological processes in vitro. Advances in cell isolation, media development, substrates, and growth surfaces are leading to protocols that provide more functionality than traditional 2D cell culture. These models may provide a more predictive analysis and result in a more streamlined process of drug discovery and development. In this webinar, we will discuss recent developments in 3D modeling using ATCC primary and hTERT immortalized cells in areas such as cancer, wound healing, and respiratory studies.
Register for a session - 10:00 AM ET or 3:00 PM ET.


Browse and view past webinars ON DEMAND



Corning Logo- Free online cell culture and assay training webinars